Please assess the completion status of the following clinical trial:

Trial Title: SonoVue Guided Prostate Biopsy

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male patient, age ≥ 40 years old~* Optimization part only: Diagnosis of prostate cancer~* Main part: Suspected prostate cancer scheduled for first biopsy and tPSA ≤ 10 ng/mL OR already submitted to one systematic bioptic procedure with negative results currently under follow up procedure due to a persistent indication.~* Written Informed Consent and willing to comply with protocol requirements~Exclusion Criteria:~* Documented acute prostatitis or urinary tract infections~* Known allergy to sulphur hexafluoride micro bubbles~* Any clinically unstable cardiac condition within 7 days prior to SonoVue® administration such as:~* evolving or ongoing myocardial infarction~* typical angina at rest within the previous 7 days~* significant worsening of cardiac symptoms within the previous 7 days~* recent coronary artery intervention or other factors suggesting clinical instability (e.g., recent deterioration of ECG, laboratory or clinical findings)~* acute cardiac failure, class III/IV cardiac failure~* severe cardiac rhythm disorders~* right-to-left shunts~* Severe pulmonary hypertension or uncontrolled systemic hypertension or respiratory distress syndrome~* Bioptic procedure within 30 days before admission into this study (this exclusion criterion is only for the main part of the study)~* Determined by the Investigator that the patient is clinically unsuitable for the study~* Participation in a concurrent clinical trial or in another trial within the past 30 days~* Repeated participation in this trial (the patient should not be enrolled twice in the present study)

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SonoVue guided biopsy (Type: EXPERIMENTAL): None
- Systematic biopsy (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).